United States

 Securities and Exchange Commission

Washington, DC 20549

 

 

 

 Form 10-K

 

x Annual Report Pursuant to Section 13 or 15(d)

Of the Securities Exchange Act of 1934

For the fiscal year ended December 31, 2013

OR

¨ Transition Report Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Commission file number: 000-31279

 

OurPet’s Company

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Colorado

34-1480558

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer
Identification No.)

 

 

1300 East Street, Fairport Harbor, OH

44077

(Address of principal executive offices)

(Zip code)

  

Issuer’s telephone number: (440) 354-6500

 

Securities registered under Section 12(b) of the Exchange Act: None

 

Securities registered under Section 12(g) of the Exchange Act: Common Stock, no par value

 

 

 

Indicate by check mark whether the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.  ¨  Yes    x  No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Exchange Act.  ¨  Yes    x  No

 

Indicate by check mark if the registrant: (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for past 90 days.  x  Yes     ¨  No

 

Indicate by check mark whether the registrant has submitted electronically and posted on its Corporate web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  x  Yes    ¨  No

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.  x

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check One):

 

Large Accelerated Filer  ¨

 

Accelerated Filer  ¨

Non-Accelerated Filer  ¨

 

Smaller Reporting Company  x

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act)  
¨  Yes     x  No

 

Registrant’s revenues for the fiscal year ended December 31, 2013 were $21,554,106. The aggregate market value of the common stock of the registrant, no par value per share (the “Common Stock”), held by non-affiliates of registrant was $3,696,304 as of June 28, 2013. As of March 10, 2014, the registrant had outstanding 16,695,462 shares of Common Stock.

 

Documents Incorporated by Reference.

 

Portions of the registrant’s definitive proxy statement for the 2013 Annual Meeting of shareholders of OurPet’s Company are incorporated by reference into Part III of this Form 10-K. Except as otherwise stated, the information in this Form 10-K is as of December 31, 2013.

 

www.ourpets.com  

 

 

 

 

OURPET’S COMPANY

 

FORM 10-K

 

For The Fiscal Year Ended December 31, 2013

INDEX

 

 

 

Page

PART I

 

 

 

 

 

Item 1.

Business

3

 

 

 

Item 1A.

Risk Factors

5

 

 

 

Item 1B.

Unresolved Staff Comments

8

 

 

 

Item 2.

Properties

8

 

 

 

Item 3.

Legal Proceedings

9

 

 

 

Item 4.

Mine Safety Disclosures

9

 

 

 

PART II

 

 

 

 

 

Item 5.

Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

9

 

 

 

Item 6

Selected Financial Data

10

 

 

 

Item 7.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

10

 

 

 

Item 8.

Financial Statements and Supplementary Data

18

 

 

 

Item 9.

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

18

 

 

 

Item 9A.

Controls and Procedures

18

 

 

 

Item 9B.

Other Information

19

 

 

 

PART III

 

 

 

 

 

Item 10.

Directors, Executive Officers and Corporate Governance

19

 

 

 

Item 11.

Executive Compensation

19

 

 

 

Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

19

 

 

 

Item 13.

Certain Relationships and Related Transactions, and Director Independence

19

 

 

 

Item 14.

Principal Accountant Fees and Services

19

 

 

 

PART IV

 

 

 

 

 

Item 15.

Exhibits and Financial Statement Schedules

19

 

 

 

 

Signatures

25

 

 

 

 

Exhibit 11

 

 

 

 

Certifications

 

2

 

 

Forward-Looking Statements

 

This report on the Form 10-K (this “Report”) contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including, without limitation, statements regarding our cash needs and ability to fund our requirements, building of our market presence and ability to succeed as planned and our ability to successfully obtain and protect our patents. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or industry results to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. See “Item 1A. Risk Factors” for a discussion of these risks. When used in this Report, statements that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the foregoing, the words “anticipates”, “plans”, “intends”, “expects” and similar expressions are intended to identify such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this Report. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements.

 

Introductory Note

 

OurPet’s Company, a Colorado corporation, is engaged in developing, manufacturing, and marketing various proprietary products for the retail pet business. As used in this Form 10-K, the terms “OurPet’s,” “Company,” “Registrant,” “we,” “us,” and “our” mean OurPet’s Company and its consolidated subsidiaries as a whole, unless the context otherwise requires.

 

PART I

 

Item 1. Business.

 

Our management originally founded Napro, Inc. (“Napro”), an Ohio corporation, in 1985 as an enterprise for launching new ventures and acquiring companies in various lines of business. In 1996, Napro formed a wholly owned Ohio subsidiary, Virtu Company (“Virtu”), to market proprietary products to the retail pet business under the OurPet’s® label. Napro then changed its name to OurPet’s Company effective March 19, 1998. On July 16, 1998, Manticus, Inc. (“Manticus”), a Colorado corporation, obtained all of the outstanding shares of OurPet’s/Napro in exchange for 8,000,000 shares of Manticus common stock. After the transaction, the former holders of OurPet’s/Napro shares owned approximately 89% of Manticus’ shares. Effective August 10, 1998, OurPet’s/Napro was merged into Manticus and ceased to exist. Prior to this merger no affiliation or other relationship existed between Manticus and us or our shareholders. Operations for the newly merged entity were, and continue to be, conducted in Ohio. Manticus proceeded to become licensed in the State of Ohio as a foreign corporation, known as OurPet’s Company. Effective October 12, 1998, Manticus’ Articles of Incorporation were amended in the State of Colorado to reflect its new name as OurPet’s Company. After the merger, management of the former OurPet’s/Napro assumed management of the surviving company. In January 2006, OurPet’s purchased substantially all the assets of PetZone, a competitor that manufactured and distributed cat, dog and bird feeders, storage bins, and cat and dog toys to the pet specialty, mass retailers and grocery chains. In July 2010, OurPet’s purchased substantially all the assets of Cosmic Pet Products, a leading provider of catnip products, cat toys and other cat products such as scratchers and cat treats.

 

We develop and market products for improving the health, safety, comfort, and enjoyment of pets. Our mission is “To Exceed pet and guardian expectations with innovative solutions.” Our dual brand strategy is focused on OurPets® for the Pet Specialty channel and PetZone® for the food, drug and mass retail channel. The products sold have increased from the initial Big Dog Feeder® to approximately 800 products for dogs, cats, domestic and wild birds. Products are marketed under the OurPet’s®, Flappy®, Pet Zone®, SmartScoop®, Ecopure Naturals ®, Play-N-Squeak®, Durapet®, Clipnosis® , Go! Cat!Go!®, and Cosmic PetTM labels to customers, both domestic and foreign. The manufacturing of these products is subcontracted to other entities, both domestic and foreign, based upon price, delivery, and quality.

 

According to the most recent 2013/2014 APPA National Pet Owners Survey, published by the American Pet Products Manufacturers Association, Inc.® (APPA), approximately 82.5 million U.S. households reported owning a pet with an estimated pet population of 83.3 million dogs, 95.6 million cats, and 20.6 million birds.  According to Packaged Facts: Pet Supplies and Pet Care Products in the U.S., June 2013, US pet industry sales totaled $59.12 billion in 2012.  For the same period, U.S. retail sales of pet supplies (OurPet’s segment) totaled $11.5 billion, which represents an increase of 3% over 2011.  While market growth is still below pre-recession rates, the economy is expected to gradually improve and the pet market as a whole is expected to rise to $75.09 billion by 2017. Annual sales growth of pet supplies is predicted at 4.5% in 2014. Compound annual growth rate is likewise projected at 4-5% during 2012-2017. 

 

3

 

 

Market factors pointing to a healthier growth rate include the industry’s success in emphasizing the human-animal bond, driving sales of premium products; the strong market presence of upper-income households willing to spend heavily on pet supplies; the growing population of pets with specialized health needs (approximately 40% of pets are seniors) and the expansion of the pet specialty channel. In summary, the pet industry has again proven to be generally recession resistant with annual growth rates favorable to the overall economy over a business cycle.

 

We sell our products in the following market segments:

 

Mass retailers—e.g. Wal-Mart

Pet superstores—e.g. PetsMart 

Regional Pet Chains—e.g. Pet Supplies Plus

Pet catalogues—e.g. Drs. Foster & Smith 

Internet—Amazon.com

Clubs—e.g. Costco 

Military Exchange chains—e.g. AAFES

Grocery chains—e.g., Kroger 

Pet food manufacturers—e.g., Ralston Purina

Pet distributors—e.g. Bradley Caldwell 

International customers—e.g., Pet’s at Home

 

The companies listed above are intended to serve as examples only. As a standard industry practice, price lists are provided to distributors, who in turn place products with retailers. Larger retailers with a national presence will generally order product directly from us pursuant to the price list and subject to negotiated additional terms, if any. With the exception of a written price list, many of the arrangements with retailers or distributors are verbal and written contracts often do not exist. Customers submit their own standard purchase orders based on our current price list. Even the larger retailers, which might have written contracts with us, are under no obligation to purchase specific product from us. While all of the above companies may currently buy product from OurPet’s, none of these customers are under any contractual obligation to purchase a specific volume of product or to continue making any purchases in the future. We currently have approximately 250 customers to whom we sell products, with the total number and specific customers changing from time to time. With the exception of Wal-Mart, none of our customers account for 10% or more of our sales. For the year ended December 31, 2013, $5,181,565 (24.0%) of our revenue was derived from Wal-Mart.

 

We currently market products, such as: dog, cat, and bird feeders; dog and cat toys; cat and dog waste management products; catnip products; and natural, nutritional pet supplements and topical products. We conduct our marketing and sales activities through 14 employees and 20 independent sales representatives. Domestic independent sales representatives are paid commissions, which range from 3% to 15% of net sales to customers.

 

Our marketing strategies include, among others: trade shows; customer visitations; social media; telemarketing; direct mail; trade journal advertising; product sampling programs; and customer support programs, such as advertising and promotional allowances.

 

We are one of many companies in the accessory and consumable pet products market with no measurable percentage of that market. Our competition in the healthy feeding systems, interactive toys, and healthy consumable products markets are both domestic and foreign companies, many of whom manufacture their products in low cost areas such as India, the Far East, and Mexico.

 

Most of our products are proprietary and we have been granted or assigned 80 United States and international patents for dog and cat feeders and have 64 United States and international patents pending for cat and dog toys, dog feeders and natural and nutritional pet supplements and treats. We registered trademarks for “The OurPet’s Company” as our corporate identity, and “OurPets” as our pet specialty brand as well as Pet Zone® for Food, Drug and Mass retail channel. To protect our trade names we obtained 64 additional trademark registrations and applied for 11 trademark registrations, which are still pending.

 

As of March 6, 2014, we had a total of 59 employees, 48 being full time employees consisting of 4 officers; 14 employees in sales and marketing; 3 employees in business & product development; 4 employees in finance and administration; 1 employee in IT; 6 employees in operations; 1 employee in quality assurance; and a combined 15 full time and 11 part time employees in production, warehousing and shipping at our Fairport Harbor, Ohio and Mentor, Ohio facilities. Most of our manufacturing is subcontracted to outside vendors. However, we do perform some light manufacturing at our Mentor, Ohio facility for the production of catnip products. None of our employees are subject to a collective bargaining agreement. We have not experienced any work stoppages and believe we have good relations with our employees.

 

We conduct our own research and development activities and also use outside sources to perform specific projects such as engineering drawings and prototype models. Research and development costs are charged to expenses as incurred, and totaled $372,781 for the year ended December 31, 2013 and $226,307 for the year ended December 31, 2012.

 

4

 

 

Item 1A. Risk Factors.

 

An investment in our common stock involves a substantial degree of risk. Before making an investment decision, you should give careful consideration to the following risk factors in addition to the other information contained in this report. The following risk factors, however, may not reflect all of the risks associated with our business or an investment in our common stock.

 

We are still building our market presence and are subject to substantial competition that could inhibit our ability to succeed as planned.

 

We are one of many companies in the pet product market with no measurable percentage of that market. We are still building our market presence as we compete with domestic and foreign companies, who also manufacture their products in low cost areas such as Mexico, India, and the Far East. Any reputation that we may successfully gain with retailers for quality product does not necessarily translate into name recognition or increased market share with the end consumer. Our products may not be well received by the pet owners, or other companies may surpass us in product innovations. Certain retailers have been adversely impacted by economic conditions causing them to file for bankruptcy protection. This could adversely affect our sales if this trend continues or these retailers are unable to emerge from bankruptcy protection.

  

Financing may not be available when required by us.

 

We may need financing for working capital, new product launches, warehouse equipment, research and development of new products, strategic acquisitions, and molds and tooling to produce new products. If the financial resources are not available when needed or are not available on affordable terms, then our ability to fund operations will be hampered.

 

The loss of key personnel could adversely affect our operations.

 

We are and will continue to be dependent on our key management personnel: Dr. Steven Tsengas, Chairman and Chief Executive Officer; Konstantine S. Tsengas, Vice President of Operations and Secretary; and Scott R. Mendes, Chief Financial Officer. The loss of one or more of these individuals could have a material adverse effect on our business and operations. In addition, we will need to attract and retain other qualified individuals to satisfy our personnel needs. We may not succeed in retaining our key management personnel or in attracting and retaining new employees.

 

The inability to successfully obtain or protect our patents could harm our competitive advantage.

 

Our success will depend, in part, on our ability to maintain protection for our products under United States patent laws, to preserve our trade secrets, and to operate without infringing the proprietary rights of third parties. We have 80 issued or assigned U.S. and international patents. The issuance of a patent, however, is not conclusive as to its validity, scope, or enforceability; and competitors might successfully challenge the validity, scope, or enforceability of any issued patents should we try to enforce them. Furthermore, unauthorized parties may attempt to copy or otherwise obtain and use our patented products. Identifying unauthorized use of our intellectual property is difficult because we may be unable to monitor the processes and materials employed by other parties. Plus the end products of our proprietary technology may be commodities from which it would be difficult to ascertain the methods or materials used in their manufacture. We cannot be certain that the steps we have taken will prevent unauthorized use of our technology, particularly in foreign countries where enforcement of intellectual property rights is more difficult than in the United States. We also have 64 U.S. and international patent applications pending. Patent applications may not successfully result in an issued patent. Issued patents are still subject to challenges and infringements. If we fail to obtain or protect our patents, our competitive advantage may be harmed.

 

Our ability to compete may decline if we are required to enforce or defend our intellectual property rights through costly litigation or administrative proceedings. 

 

On February 16, 2011 we settled a litigation filed against us by a competitor that alleged we infringed upon certain patents for self-cleaning litter boxes. If we had not been successful in defending this litigation and settling it, we would not have been able to sell our SmartScoop™ self-scooping cat litter box. Plus we could have incurred costs for damages paid to our competitor and for the write-off of our product development and tooling costs for our product. While we were successful in defending against this litigation, the cost of our defense has had a negative impact on our profitability. Overall, proceedings to enforce or defend our intellectual property rights could result in substantial costs, even if the eventual outcomes are favorable to us. These additional costs would divert both funds and other resources from our business objectives. If the outcome of any such proceedings is unfavorable and competitors are able to use our patented products without payment to us, our ability to compete effectively could be harmed.

 

5

 

 

Many competitors who have greater resources and experience than we do may develop patented products that make ours obsolete.

 

We face intense competition in our business and many of these competitors have significantly greater financial and human resources than we do. Our future success will depend on our ability to maintain a competitive position with respect to technological advances. Our competitors may develop patented products that are superior alternatives to ours, thereby rendering our products obsolete. If that happens, we may need to license these technologies; and we may not be able to obtain licenses on reasonable terms, if at all, which could cause harm to our business.

 

We may be involved in a number of legal proceedings and audits which could adversely affect our business, financial condition and results of operations.

 

Our business requires compliance with a great variety of laws and regulations. Failure to achieve compliance could subject us to lawsuits and other proceedings, and lead to damage awards, fines and penalties. We may become involved, in a number of legal proceedings and audits including grand jury investigations, government and agency investigations, and consumer, tort and other litigation. In addition, if we fail to comply with applicable employment laws and regulations, particularly wage and hour laws, we could be subject to government enforcement action and employee litigation, which could adversely affect our results of operations by increasing our costs, reducing our margins, damaging our reputation and lowering our sales. Litigation is inherently uncertain and the outcome of any such proceeding would be very difficult to predict. Ultimately, if we become subject to any such legal proceeding and receive an unfavorable outcome, we could be required to take, or refrain from taking, actions that would negatively affect our operations or would require us to pay substantial amounts of money adversely affecting our financial condition and results of operations. Additionally, defending against these lawsuits and proceedings may involve significant expense and diversion of management’s attention and resources from the operation of the business.

 

The exercise of too many warrants and stock options would dilute the value of the Common Stock and stockholder voting power.

 

We currently have 16,657,660 shares of Common Stock outstanding which could be diluted by the following potential issuances of Common Stock. As of December 31, 2013, we had outstanding 187,116 shares of Convertible Preferred Stock (“Preferred Stock”) convertible into 1,871,160 shares of Common Stock at conversion rates of $1.00 per share for 63,500 shares of Preferred Stock and $.70 per share for 123,616 shares of Preferred Stock. Also as of December 31, 2013, we had outstanding 1,483,334 warrants to purchase an aggregate of 1,483,334 shares of Common Stock at exercise prices ranging from $0.4183 to $0.9836 per share and options to purchase an aggregate of 1,400,208 shares of Common Stock at exercise prices ranging from $0.222 to $0.980 per share. We have reserved an aggregate of 2,459,500 shares of Common Stock for issuance under the 1999 Stock Option Plan and the 2008 Stock Option Plan as of the date of this report. In addition, the exercise of such warrants and options could have a material adverse effect on the future market price of, and liquidity in the market for, shares of Common Stock trading in the over-the-counter market. Further, while these warrants and options are outstanding, our ability to obtain additional financing on favorable terms may be adversely affected.

 

Resale of our securities is and will continue to be subject to restrictions.

 

Our securities are subject to Rule 15g-9 under the Exchange Act, which imposes additional sales practice requirements on broker-dealers that sell securities to persons other than established customers and “accredited investors” (generally, individuals with a net worth in excess of $1,000,000 or an annual income exceeding $200,000 or $300,000 together with their spouse). For transactions covered by such rule, a broker-dealer must make a special suitability determination for the purchaser and receive the purchaser’s written consent to the transaction prior to the sale. Consequently, this rule may adversely affect the ability of broker-dealers to sell our securities and may adversely affect the ability of the holders of our securities to sell such securities in the secondary market.

 

SEC regulations define a “penny stock” to be any non-NASDAQ equity security that has a market price (as therein defined) of less than $5.00 per share or with an exercise price of less than $5.00 per share, subject to certain exceptions. Prior to any transaction involving a penny stock, unless exempt, SEC rules require delivery of a disclosure schedule prepared by the broker-dealer relating to the penny stock market. Disclosure is also required to be made about commissions payable to both the broker-dealer and the registered representative and about current quotations for the securities. Finally, monthly statements are required to be sent disclosing recent price information for the penny stock held in the account and information on the limited market in penny stocks.

 

6

 

 

Like other small-cap companies, the market price of our common stock can be volatile, and sales of shares by our directors and officers could cause decreases in price.

 

The market price of the securities of many emerging companies similar to ours has been highly volatile, experiencing wide fluctuations not necessarily related to the operating performance of such companies. Factors such as our operating results, announcements by us or our competitors concerning innovations, and new products or systems may have a significant impact on the market price of our securities. In addition, as a smaller public company, our common stock typically has a lower trading volume than Fortune 500 companies and other larger public companies. We have experienced and expect to continue experiencing limited trading volume in our Common Stock, which may have a significant effect on the market price of our common stock. As of March 10, 2014, our directors and officers and their affiliates controlled more than 60.0% of our outstanding shares, which contributes to our low public float, and sales by those individuals could be perceived unfavorably in the market and adversely affect the price of our common stock.

 

We may experience impairment charges of our goodwill and other intangible assets.

 

We are required to evaluate goodwill and other intangible assets for impairment at least annually, and between annual tests if events or circumstances warrant such a test. These events or circumstances could include a significant long-term adverse change in the business climate, poor indicators of operating performance, or a sale or disposition of a significant area of business. For any of the goodwill or intangible assets, if we determine that the fair value is less than the carrying value, an impairment loss will be recorded in our statement of operations. The determination of fair value is a highly subjective exercise and can produce significantly different results based on the assumptions used and methodologies employed. If our projected long term sales growth rate, profit margins, or terminal growth rate are considerably lower and/or the assumed weighted-average cost of capital is considerably higher, future testing may indicate impairment. We would then have to record a non-cash impairment loss in our statement of operations. See notes to the consolidated financial statements included in this Annual Report on Form 10-K.

 

Our officers and directors own a controlling interest in our stock and investors have a limited voice in our management.

 

The Company’s executive officers and directors and their affiliates together control more than 60% of the Company’s voting shares outstanding. As a result, these stockholders, if they act together, will be able to control all matters requiring the Company’s stockholders’ approval, including the election of directors and approval of significant corporate transactions. This concentration of ownership may delay, prevent or deter a change in control, and could deprive the company’s stockholders of an opportunity to receive a premium for their common stock as part of a sale of the Company or its assets.

 

Our actual results of operations could differ from estimates used to prepare our financial statements.

 

In preparing our financial statements in accordance with generally accepted accounting principles, our management often must make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, expenses and related disclosures at the date of the financial statements and during the reporting period. Some of those judgments can be subjective and complex, and actual results could differ materially from those estimates, which, in turn, may impact earnings reported for a certain period.

 

Our Company’s operations could give rise to risk in cyber security attacks.

 

On October 13, 2011, the SEC’s Division of Corporation Finance issued Topic No.2, Cyber security, relating to cyber security risks and cyber incidents. We rely extensively on computer systems to process transactions, maintain information and manage our business. Disruptions in our computer systems could impact our ability to service our customers and adversely affect our sales and operations.

 

Failure to maintain effective internal controls in accordance with Section 404 of the Sarbanes-Oxley Act could have a material adverse effect on our business and stock price.

 

Section 404 of the Sarbanes-Oxley Act of 2002 contains provisions requiring an annual assessment by management, as of the end of the fiscal year, of the effectiveness of internal control for financial reporting, as well as attestation and reporting by independent auditors on our internal control over financial reporting as well as other control-related matters. Because we are currently a smaller reporting company, our independent auditors are not required to attest to our internal controls over financial reporting in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act.

 

Compliance with Section 404 is both costly and challenging. Going forward, there is a risk that we will not be able to conclude that our internal control over financial reporting is effective as required by Section 404. Further, during the course of our testing we may identify deficiencies that we may not be able to remediate in time to meet the deadlines imposed under the Sarbanes-Oxley Act for compliance with Section 404. Moreover, effective internal controls, particularly those related to revenue recognition, are necessary for us to produce reliable financial reports and are important to help prevent financial fraud. If we cannot provide reliable financial reports or prevent fraud, our business and operating results could be harmed, investors could lose confidence in our reported financial information, and the trading price of our stock could be adversely affected.

 

7

 

 

Our credit facilities contain restrictive covenants that may reduce our flexibility, and adversely affect our business, earnings, cash flow, liquidity and financial condition.

 

The terms of our credit facilities impose significant restrictions on our ability and, in some cases, the ability of our subsidiaries, to take a number of actions that we may otherwise desire to take, including:

 

requiring us to dedicate a substantial portion of our cash flow from operations to the payment of principal and interest on our indebtedness, thereby reducing the availability of cash flow for working capital, capital expenditures and other business activities,

 

requiring us to meet certain financial tests, which may affect our flexibility in planning for, or reacting to, changes in our business and the industries in which we operate,

 

limiting our ability to sell assets, make investments in or acquire assets of, or merge or consolidate with, other companies,

 

limiting our ability to repurchase or redeem our stock or enter into transactions with our shareholders or affiliates, and

 

limiting our ability to grant liens, incur additional indebtedness or contingent obligations or obtain additional financing for working capital, capital expenditures, acquisitions and general corporate and other activities.

 

These covenants place constraints on our business and may adversely affect our growth, business, earnings, cash flow, liquidity, and financial condition. Our failure to comply with any of the financial covenants in the credit facilities may result in an event of default which, if not cured or waived, could result in the acceleration of the debt under the credit facilities or other agreements we may enter into from time to time that contain cross-acceleration or cross-default provisions. If this occurs, there can be no assurance that we would be able to refinance or otherwise repay such indebtedness, which could result in a material adverse effect on our business, earnings, cash flow, liquidity and financial condition.

 

Item 1B. Unresolved Staff Comments – None.

 

Item 2. Properties.

 

We lease a 64,000 square foot production, warehouse and office facility in Fairport Harbor, Ohio, from a related entity, Senk Properties LLC, at a current monthly rental of $27,250 plus real estate taxes. Senk Properties is a limited liability company owned by Dr. Steven Tsengas, Konstantine S. Tsengas, Nicholas S. Tsengas, and Evangelia S. Tsengas. Dr. Tsengas is our Chairman, Chief Executive Officer, a director and a major stockholder of the Company. Konstantine Tsengas is our Vice President and Secretary, as well as being a stockholder. Nicholas Tsengas and Evangelia Tsengas are both stockholders of OurPet’s.

 

The Company entered into a ten year lease with Senk Properties which was effective upon completion of the 36,000 square foot warehouse expansion on June 1, 2007. The monthly rental was $26,667 for the first two years, $28,417 for the next three years, and $30,167 from June 1, 2012 through August 31, 2012 of the sixth year. On August 10, 2012, the Company executed a new ten and one half year lease that reduced monthly payments effective September 1, 2012. The new lease’s payment schedule is $27,250 per month for the first two years, then $29,013 per month for the next two years, then $30,827 for the next three years, then $32,587 for the next two years, and lastly $34,347 for the final eighteen months, all plus real estate taxes. The Company has the option to extend the lease for an additional ten years at a rental amount to be mutually agreed upon.

 

On December 30, 2011 the Company entered into a second lease with Senk Properties for a 26,000 square foot production warehouse and office facility in Mentor, Ohio with payments due on the first day of each month starting on January 1, 2012. This facility replaces the Hagerstown, Maryland facility which housed Cosmic Pet operations until its lease expired in July of 2012. The monthly rental rate is $8,542 for the first two years, then increases to $9,083 for the next two years, $9,732 for the next two years, $10,056 for the next year, $10,597 for the next two years, and $10,813 for the last year, all plus real estate taxes. In 2013, the monthly rental rate was $8,542 as we were in the second year of the lease. The Company has the option to extend the lease for an additional ten years at a rent amount to be mutually agreed upon. 

 

We believe these facilities will provide adequate warehouse and office space to meet our needs for the foreseeable future. Any longer-range future growth can be accommodated by expanding these facilities or leasing nearby space. In the opinion of our management, all of the properties described here are adequately covered by insurance and such coverage is in accordance with the requirements contained in our various debt agreements.

 

8

 

 

Item 3. Legal Proceedings.

  

On January 23, 2012, we received a Notice of Impending Legal Action by Law Enforcement from the Office of the District Attorney for the County of Solano, California, in connection with our waste management PIK-Up Bags. The notice cited a violation of California Public Resources Code 42357(b) which prohibits any person from selling any plastic bag in the State of California that claims to be “biodegradable,” “degradable,” or “decomposable” if it does not break down, fragment, biodegrade, or decompose in a landfill or other environment. While our “PIK-up bags” packaging stated they were biodegradable “except as defined by the State of California,” we were required to cease selling such product in the State of California. We may also be subject to financial penalties as a result of this violation; however, because the matter is still pending with the district attorney, we remain unable to quantify what the penalties may be at this time. We continue to cooperate with the State of California and do not have any reason to believe that this action will result in any judgments or fines against OurPet’s that would have a material adverse effect or impact in our financial position, liquidity, or results of operation.

 

In addition to the above matter and in the normal course of conducting our business, we may become involved in various other litigation matters, including, but not limited to, preference claims by debtors in bankruptcy proceedings. We are not a party to any litigation or governmental proceeding which our management or legal representatives believe could result in any judgments or fines against us that would have a material adverse effect or impact in our financial position, liquidity, or results of operation.

 

Item 4. Mine Safety Disclosures – Not Applicable.

 

PART II

 

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities.

 

Our Common Stock is quoted on the OTC Markets OTCQB under the symbol “OPCO” and has traded under the symbol “OPCO” since December 13, 2001. The following table sets forth, for each of the quarters indicated, the high and low bid quotations per share of Common Stock in the over-the-counter market (source, the Nasdaq Stock Chart). The bid quotations in the over-the-counter market represent prices between securities dealers, do not include retail markups, markdowns, or commissions and may not represent actual transactions.

  

Quarter Ended

 

High

 

 

Low

 

March 31, 2012

 

 

0.59

 

 

 

0.40

 

June 30, 2012

 

 

0.54

 

 

 

0.36

 

September 30, 2012

 

 

0.59

 

 

 

0.40

 

December 31, 2012

 

 

0.45

 

 

 

0.35

 

March 31, 2013

 

 

0.85

 

 

 

0.38

 

June 30, 2013

 

 

0.65

 

 

 

0.50

 

September 30, 2013

 

 

0.62

 

 

 

0.51

 

December 31, 2013

 

 

0.98

 

 

 

0.53

 

 

As of March 10, 2014, we had approximately 660 holders of record of our Common Stock.

 

Each share of Common Stock has an equal right to receive dividends when and if the Board of Directors decides to declare a dividend after payment of any accrued dividends on the Preferred Stock. We have never paid any cash dividends nor do we intend, in the foreseeable future, to make any cash distributions to our common stockholders as dividends. We cannot currently distribute cash dividends to common stockholders without violating our loan agreement with our bank.

 

There are no conversion rights or redemption or sinking fund provisions with respect to the Common Stock. All of the outstanding shares of Common Stock are fully paid and non-assessable.

 

On January 28, 2010 and February 1, 2010, OurPet’s sold an aggregate of 123,616 shares of its Series 2009 Preferred Stock in a private placement to a total of 15 accredited investors. All shares in the private placement were sold at a price of $7.00 a share for a total of $865,312. Payment for the shares comprised of $595,000 in cash and $270,312 in converted debt (including accrued interest). All were previously reported in Form 8-K filed February 2, 2010 except for 6,572 shares totaling $46,004 purchased by two additional accredited investors on February 1, 2010. All shares are convertible at any time into Common Stock shares at a conversion price of $.70/common share, subject to adjustment for stock splits, combinations and similar transactions. All shares receive a 6% ($.42) cash dividend payable on December 1st of each year provided that payment may be deferred if necessary for our compliance with our loan covenants. We have the limited right to convert the shares into Common Stock at any time after the trading price of our Common Stock reaches $1.50 per share for twenty (20) consecutive days. In accordance with the above provisions, in December 2013 and 2012 the Company paid $51,920 each year in cash dividends to holders of this Series 2009 Preferred Stock.

 

9

 

 

The preferred shares sold were not registered under the Securities Act of 1933, as amended (the “Act”), in reliance on the private offering exemption from registration provided by Section 4(a)(2) of the Act and Rule 506 of Regulation D of the rules promulgated under the Act. We did not utilize an underwriter or placement agent in connection with the private placement.  

 

In 2012, the following warrants were issued and not registered under the Securities Act of 1933:

 

Date
Granted

 

Number
Granted

 

Exercise Price
at Issue

 

 

Expiration Date

 

To Whom

 

Reason Warrants
Were Issued

11-8-2012

 

100,000

 

$

0.50

 

 

11-8-2017

 

Pet Zone

 

In exchange for funds loaned

11-8-2012

 

50,000

 

$

0.50

 

 

11-8-2017

 

SENK

 

In exchange for funds loaned

11-8-2012

 

50,000

 

$

0.50

 

 

11-8-2017

 

Nelson Mostow

 

In exchange for funds loaned

11-8-2012

 

150,000

 

$

0.50

 

 

11-8-2017

 

LJR

 

In exchange for funds loaned

12-7-2012

 

375,000

 

$

0.42

 

 

12-7-2017

 

Dr. Steve and Evangelia Tsengas

 

Guarantee of Loan

 

In 2013, the following warrants were issued and not registered under the Securities Act of 1933:

 

Date
Granted

 

Number
Granted

 

Exercise Price
at Issue

 

 

Expiration
Date

 

To Whom

 

Reason Warrants  
Were Issued

2-18-2013

 

62,500

 

$

0.46

 

 

2-18-2018

 

Confusion, Inc.

 

Consulting Agreement

10-10-2013

 

125,000

 

$

0.55

 

 

10-10-2018

 

Dr. Steve and Evangelia Tsengas

 

Guarantee of Loan

10-18-2013

 

15,000

 

$

0.60

 

 

10-18-2018

 

Robert A. Lentz

 

Payment for Services

 

The warrants in both years were not registered under the Securities Act of 1933, as amended (the “Act”), in reliance on the private offering exemption from registration provided by Section 4(a)(2) of the Act and Rule 506 of Regulation D of the rules promulgated under the Act. We also did not utilize an underwriter or placement agent in connection with the issuance of the foregoing warrants.  

 

Item 6. Selected Financial Data.

 

Not applicable.

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

This discussion should be read in conjunction with the consolidated financial statements, notes, and tables included elsewhere in this Form 10-K. Management’s discussion and analysis contains forward-looking statements that are provided to assist in the understanding of anticipated future performance. However, future performance involves risks and uncertainties which may cause actual results to differ materially from those expressed in the forward-looking statements. See “Forward-Looking Statements.”

  

 

Overview

 

OurPet’s develops, designs, produces, and markets a broad line of consumer brands containing innovative, high-quality accessory and consumable pet products. We have primarily adopted a two brand strategy: OurPets® for the Pet Specialty channel and Pet Zone® for the food, drug and mass retail channel. We are continuing with a number of sub-brands/descriptors comprised of our previous brands: Play-N-Squeak® www.playnsqueak.com; SmartScoop® www.smartscoop.com; ecoPure Naturals® www.ecopurenaturals.com; Flappy® Dog Toys www.flappydogtoys.com; Go! Cat Go®! cat toys; Cosmic Pet® cat products cosmiccatnip.com ; Durapet® premium stainless steel bowls; petzonebrand.com ® dog waste management products, wild bird feeders, dog houses, and a variety of raised feeders. These products are manufactured by domestic and foreign subcontractors and then sold by us to retailers and distributors who then sell the products to the end consumer.

 

Consolidated net revenue for 2013 was $21,554,106, an increase of approximately 6.9% in revenue from $20,160,751 in 2012. Sales to distributors, e-commerce customers, national chains, and regional chains all increased. The largest growth in dollar terms came from distributors which grew by approximately $627,000 from 2012 to 2013.

 

Cost of goods sold increased by a net of $172,034 or 1.2%, from $14,703,465 in 2012 to $14,875,499 in 2013. Our variable and fixed warehouse and overhead costs increased in total by approximately $56,000, or 2.2%, from the comparable twelve months in 2012. Gross profit dollars increased by approximately $1,221,000 to $6,678,607 for 2013 from $5,457,286 the prior year. Gross profit margin increased 3.9 percentage points to 31.0% in 2013 from 27.1% in 2012.

 

10

 

 

Selling, general and administrative (“S, G & A”) expenses in 2013 were $4,960,802, a decrease of 1.7%, or $83,969, from $5,044,771 in 2012.

 

Interest expense for 2013 was $160,572, an increase of $2,303, or 1.5%, from $158,269 in 2012. Income tax expense in 2013 increased to $660,893 from $58,298 in 2012.

 

As a result of all the changes above, net income increased by $878,255, from $192,740 in 2012 to $1,070,995 in 2013.

 

During 2013, we had a net decrease of $426,000 in borrowings from our line of credit facilities with our bank under which we can borrow up to $5,000,000 based on the level of qualifying accounts receivable and inventories. At December 31, 2013 and December 31, 2012 we had balances of $1,833,032 and $2,259,032, respectively, under the line of credit with our bank at an interest rate of prime plus .5%. At December 31, 2013, the Company was in compliance with all bank financial covenants.

 

The following summarizes our financing activities in 2013:

 

·

The Company repaid $150,000 of the principal and all accrued interest on the $300,000 subordinated note issued in 2008 and due on October 31, 2012. This loan (including accrued interest) was not paid when due since at that time it would have put the Company in further violation of the bank’s debt service coverage ratio.

 

·

In June 2013, the Company received $125,000 as part of the Lake County Economic Development Loan Program. This new loan is payable over a five year term beginning in July 2013 in equal monthly installments of $2,359, which includes interest accruing at a fixed rate of 5.0%.

 

·

In November 2013, we extended our $5,000,000 credit facility through June 30, 2015.

 

Our short-term and long-term liquidity will continue to depend on our ability to achieve positive cash-flow on our operations and to increase sales of our products. In 2013, we funded our operating cash requirements primarily with net income. In 2014, we should be able to fund our operating cash requirements through net income and our working capital line of credit. Based on our bank’s amended loan covenants we expect to comply with the debt service coverage ratio and tangible net worth required by our bank to maintain our line of credit through the end of 2014.

 

 Liquidity and Capital Resources

 

Our operating activities provide cash from the sale of our products to customers with the principal use of cash being for the payments to suppliers that manufacture our products and for freight charges for shipments to our warehouse and to our customers. Our investing activities use cash mostly for the acquisition of equipment such as tooling, computers, and software. Our financing activities provide cash, if needed, under our lines of credit with our bank that had approximately $1,941,323 in available funds at December 31, 2013 based upon the balance of accounts receivable and inventories at that date.

 

As of December 31, 2013, we had $3,051,996 in principal amount of indebtedness consisting of:

  

Bank line of credit - $5,000,000

 

Prime plus .5%

 

$

1,833,032

 

Lake County Economic Development Loan

 

5.0%

 

 

113,856

 

Bank term note ($500,000 original balance)

 

5.45%

 

 

333,334

 

Ohio 166 note ($225,000 original balance)

 

3.25%

 

 

131,634

 

Contributor notes payable

 

Prime plus 3% and  prime plus 5%

 

 

500,000

 

Capitalized leases

 

11.88% and 9.9%

 

 

40,140

 

Other notes payable

 

Prime plus 3% & 10%

 

 

100,000

 

  

The bank line of credit indebtedness is $1,833,032, which is comprised of a single line of credit under which we can borrow up to a total of $5,000,000 based on the level of qualifying accounts receivable and inventories. Total eligible collateral at December 31, 2013 was $3,774,355. The $5,000,000 line of credit is a two year revolver and therefore is classified as a long term liability on our balance sheet. Prior to the quarter ending June 30, 2011, the line of credit had always been a one year agreement and therefore classified as a current liability. Currently the $5,000,000 line of credit has been renewed by the bank through June 30, 2015. Under our agreement with the bank we are required to: (i) maintain a debt service coverage ratio of at least 1.15; (ii) maintain a tangible net worth of no less than $4,500,000; and (iii) obtain the bank’s permission to incur additional indebtedness, make any expenditures for property and equipment in excess of $500,000 in any fiscal year, redeem any of our capital stock, or pay cash dividends other than dividends on our Preferred Stock (subject to meeting the debt service coverage ratio).

 

11

 

 

The rest of the line items in the table on the previous page, as well as other items, are explained below.

 

2013 Financing

 

In April, 2013, our bank approved a repayment schedule for all accrued interest and principal related to the outstanding $300,000 subordinated note, issued in 2008 and due to be paid in full on October 31, 2012. As explained in our Annual Report on Form 10-K filed with the SEC on March 29, 2013, this loan (including accrued interest) was not paid when due since at that time it would have put the Company in further violation of the bank’s debt service coverage ratio. Effective November 1, 2012, per the terms of this note, the interest rate increased to prime plus 500 basis points (8.25%). The repayment is conditioned on the Company meeting the bank’s revised debt service coverage ratio each quarter. In April 2013, the Company repaid all accrued interest (approximately $82,000). In the third quarter of 2013, the Company repaid $75,000 of the outstanding principal plus approximately $6,000 in newly accrued interest. In the fourth quarter of 2013, the Company repaid another $75,000 of the outstanding principal plus approximately $5,000 in newly accrued interest. The Company plans to continue paying $75,000 of the outstanding principal and any accrued interest per quarter until the loan is repaid in full.

 

Also in April 2013, the Company entered into a capital lease for the purchase of a truck for transporting products between our Fairport Harbor and Mentor facilities in Ohio. The principal amount of the lease is $20,816 and is payable over a four year term in equal monthly installments of $527.

 

In June 2013, the Company received $125,000 in funds as part of the Lake County Economic Development Loan Program. This new loan is payable over a five year term beginning in July 2013 in equal monthly installments of $2,359, which includes interest accruing at a fixed rate of 5.0%. The Company used the funds towards the purchase of certain information technology equipment, packaging equipment, and tooling for new products. The loan is secured by this equipment.

 

As referenced above, in November 2013, we extended our $5,000,000 credit facility through June 30, 2015. The credit facility is collateralized by a security interest in the cash, accounts receivable, inventory and all other property and assets of OurPet’s and its subsidiaries. Steven Tsengas, OurPet’s Chairman of the Board and Chief Executive Officer, and his wife, Evangelia Tsengas, personally guaranteed the repayment of the credit facility. In consideration for their continued guarantees through June 30, 2015, they were granted 125,000 warrants at an exercise price of $.55/share for the right to purchase OurPet’s common stock. The warrants vested immediately and have a five year term. At year end the warrants were adjusted to 125,498 warrants exercisable at $.548/share in accordance with the warrants anti-dilution provisions.

 

2012 Financing

 

On March 26, 2012, our bank amended how we calculate the debt service coverage ratio for the reporting periods ending March 31, 2012, June 30, 2012 and September 30, 2012. A copy of the “Loan Amendment” was filed as Exhibit 10.66 with the Company’s 10-K as filed on April 4, 2012. At September 30, 2012, we were not in compliance with this covenant and had a debt service coverage ratio of 0.75 (versus the required 1.15) and a tangible net worth of $4,676,948. We received a covenant waiver from our bank for the trailing twelve months ended September 30, 2012, whereby the bank waived its rights and remedies of our breaches of the covenants described above. A copy of the waiver was attached as Exhibit 10.70 to our Quarterly Report on Form 10-Q filed with the SEC on November 14, 2012.

 

On June 11, 2012, the Company entered into a capital lease for equipment purchased in connection with our total warehouse logistics initiatives. This equipment has allowed us to set up wireless connectivity throughout our Fairport Harbor facility. The capital lease is payable in 48 monthly payments of $838 per month from July 2012 through June 2016. As of December 31, 2013, the remaining balance on this capital lease totaled $22,252.

 

On November 8, 2012, the Company received $350,000 in funds and issued $350,000 of subordinated notes to four parties, two of which are affiliated with OurPet’s. The notes have a three year term, accrue interest at a variable rate of prime plus three percent (currently 6.25%), and are payable with accrued interest on November 8, 2015. In connection with these new notes, the Company also issued 350,000 warrants to the loan participants at a ratio of one warrant for each one dollar of funds loaned. The warrants vested immediately, have an exercise price of $.50 per share, and have a five year term expiring on November 8, 2017. Subsequent to their issuance the warrants were adjusted to 351,395 warrants exercisable at $.498/share in accordance with the warrants anti-dilution provisions.

 

12

 

 

On December 7, 2012, the Company entered into a new Business Loan Agreement and into an Amendment to Note related to OurPet’s current $5,000,000 revolving credit facility with our lender, FirstMerit Bank. Included in the Business Loan Agreement is a modification to the debt service ratio calculation whereby all newly obtained subordinated debt each year can offset unfunded capital expenditures. Pursuant to the Business Loan Agreement and the Amended Note, the credit facility was extended to June 30, 2014 at an interest rate of prime plus .5%. The credit facility is collateralized by a security interest in the cash, accounts receivable, inventory and all other property and assets of OurPet’s and Subsidiaries. Steven Tsengas, OurPet’s Chairman of the Board and Chief Executive Officer, and his wife, Evangelia Tsengas, have personally guaranteed the repayment of the Credit Facility. In consideration for their guarantees, they were granted 312,500 warrants at an exercise price of $.42/share for the right to purchase OurPet’s Common Stock. The warrants vested immediately and have a five year term. Subsequent to their issuance the warrants were adjusted to 313,746 warrants exercisable at $.418/share in accordance with the warrants anti-dilution provisions.

 

On December 7, 2012, the Company obtained a new $500,000 loan from our bank. Of these proceeds, $116,983 was used to pay off the remaining balance of the $500,000 term loan obtained on July 16, 2010. This new loan is payable over a three year term beginning in January 2013 in equal monthly principal installments of $13,889 plus accrued interest at a fixed interest rate of 5.45%. This loan is secured by our accounts receivable, inventory, equipment, trademarks and patents. Steven Tsengas, OurPet’s Chairman of the Board and Chief Executive Officer and his wife provided an unlimited guarantee of the loan and for that guarantee were granted 62,500 warrants exercisable at $.42/share for the right to purchase OurPet’s Common Stock. Subsequent to their issuance the warrants were adjusted to 62,749 warrants exercisable at $.418/share in accordance with the warrants anti-dilution provisions. As of December 31, 2013, the remaining balance on this loan totaled $333,334.

 

Contributor Agreements Prior to 2012

 

In February of 2008, we entered into contribution agreements with six contributors, all of which are affiliated with OurPet’s, pursuant to which each contributor loaned certain funds to us totaling $600,000. We used these funds for expenses related to litigation on certain of our SmartScoop™ products (the “SmartScoop™ Litigation”) and for expenses related to new product development. In consideration for these loans we (a) executed promissory notes due in two years with interest accruing at prime plus 2%, (b) issued warrants for the purchase of 300,000 shares of our Common Stock at a grant price of $0.825 per share and (c) entered into piggyback registration rights agreements with the contributors. Subsequent to their issuance the warrants’ exercise price was adjusted down to $.50. As of December 31, 2012, they were further adjusted to 306,332 warrants exercisable at $0.490 per share in accordance with the warrants’ anti-dilution provisions. The warrants expired in 2013 unexercised. The loans totaling $600,000 were paid off in late January 2010 and early February 2010 in conjunction with the Series 2009 Preferred Stock offering.

 

In June and July of 2008, we entered into additional contribution agreements with the same six contributors pursuant to which each contributor loaned funds to us totaling an additional $292,500. We used the funds for additional expenses related to the SmartScoop™ Litigation. In consideration for these loans we (a) executed promissory notes due in three years with interest compounding quarterly at prime plus 2%, (b) issued warrants for the purchase of 146,250 shares of our Common Stock at a grant price of $0.50 per share, (c) issued warrants for the purchase of 292,500 shares of our Common Stock at a grant price of $0.50 per share, which replaced 292,500 of the warrants issued in February of 2008 and (d) entered into piggyback registration rights agreements with the contributors. Subsequent to their issuance the warrants were adjusted to 455,664 warrants exercisable at $0.490 per share in accordance with the warrant anti-dilution provisions. The warrants which were originally for 146,250 shares were exercised in 2013. The warrants which were originally for 292,500 shares expired in 2013 unexercised. The loans totaling $292,500 were paid off in June and July of 2011.

 

In July and August of 2008, we entered into additional contribution agreements with two other contributors, neither of which are affiliated with OurPet’s, pursuant to which each contributor loaned certain funds to us totaling $125,000. We also used these funds for expenses related to the SmartScoop™ Litigation. In consideration for these loans we (a) executed promissory notes due in three years with interest compounding quarterly at prime plus 2%, (b) issued warrants for the purchase of 12,500 shares and 50,000 shares of our Common Stock at grant prices of $0.50 and $0.40 per share respectively, and (c) entered into piggyback registration agreements with the contributors. Subsequent to their issuance the warrants were adjusted to 12,763 and 51,105 warrants exercisable at $0.490 and $0.392 per share respectively, in accordance with the warrant anti-dilution provisions.  All of the warrants were exercised in 2013. The loans totaling $125,000 were paid off in July and August of 2011.

 

13

 

 

In October and November of 2008, we entered into additional contribution agreements with two other contributors, neither of which are affiliated to OurPet’s, pursuant to which each contributor loaned funds to us totaling $350,000. We also used these funds for expenses related to the SmartScoop™ Litigation. In consideration for these loans we (a) executed promissory notes due in three years for $50,000 and due in four years for $300,000 both with interest compounding quarterly at prime plus 2%, (b) issued warrants for the purchase of 25,000 shares and 300,000 shares of our Common Stock at option prices of $0.40 and $0.37 per share respectively, and (c) entered into piggyback registration agreements with the contributors. Subsequent to their issuance the 25,000 warrants exercisable at $0.40 per share were adjusted to 25,553 warrants exercisable at $0.392 per share and the 300,000 warrants exercisable at $0.37 per share were adjusted to 305,099 warrants exercisable at $0.363 per share in accordance with the warrant anti-dilution provisions. The warrants were exercised in 2013. In October of 2011, we paid off $50,000 of these loans leaving $300,000 due on October 31, 2012, plus accrued interest of approximately $68,000. This $300,000 loan and accrued interest were subordinated to our bank debt and were not paid in 2012 since to do so would have put the Company in further violation of the bank’s debt service coverage ratio reported in our third quarter 2012 10-Q filing. Effective November 1, 2012, per the terms of this contributor note, the interest rate on this loan increased to prime plus 500 basis points (8.25%). The Company repaid $150,000 of this loan in 2013 and plans to repay the remaining balance in 2014, as permitted upon compliance with its bank’s financial covenants.

 

Other Financing Obtained Prior to 2012

 

On September 30, 2011, the Company incurred $225,000 of long term debt payable to the State of Ohio under its 166 Program. The funds were used to purchase new tooling for our raised feeder product line. The loan is payable in equal monthly installments of $4,043 over a five year term at a fixed interest rate of 3.00% plus an additional .25% servicing fee. Payments began on November 1, 2011 with a maturity date of October 1, 2016. On December 31, 2013, the principal balance outstanding was $131,634; and at December 31, 2012, the principal balance outstanding was $175,488.

 

 The other notes payable are due in the amount of $75,000 on December 1, 2014, to Beachcraft L.P., with interest payable quarterly at prime plus 3%, and $25,000 on November 1, 2014 to Over the Hill Ltd., plus accrued interest of 10%. This indebtedness, which is secured by liens on our assets, was used to finance our equipment and working capital requirements. The agreements related to such indebtedness contain customary covenants and default provisions.

 

Our short-term and long-term liquidity will continue to depend on our ability to achieve cash-flow break even on our operations and to increase sales of our products. In 2012, we funded our operating cash requirements primarily through inventory reductions and net income. In 2013, we funded our operating cash requirements primarily by net income. In 2014, we should be able to fund our operating cash requirements through net income and the working capital line of credit if needed. Based on our bank’s amended loan covenants we expect to comply with the debt service coverage ratio and tangible net worth required by our bank to maintain our line of credit through the end of 2014. We have no material commitments for capital expenditures.

 

A schedule of our contractual obligations as of December 31, 2013 is as follows: 

 

 

 

Payments Due By Period

 

Contractual Obligation

 

Total

 

 

Less than 1
year

 

 

1-3
years

 

 

4-5
years

 

 

After 5
years

 

Short and Long Term Debt

 

$

3,011,855

 

 

$

484,995

 

 

$

2,486,035

 

 

$

40,825

 

 

$

-0-

 

Capital Lease Obligations

 

 

40,141

 

 

 

12,581

 

 

 

25,498

 

 

 

2,062

 

 

 

-0-

 

Purchase Obligations

 

 

-0-

 

 

 

-0-

 

 

 

-0-

 

 

 

-0-

 

 

 

-0-

 

Other Long Term Liabilities

 

 

-0-

 

 

 

-0-

 

 

 

-0-

 

 

 

-0-

 

 

 

-0-

 

Operating Leases

 

 

5,089,768

 

 

 

512,732

 

 

 

1,067,170

 

 

 

1,114,406

 

 

 

2,395,460

 

Total Contractual Cash Obligations

 

$

8,141,764

 

 

$

1,010,308

 

 

$

3,578,703

 

 

$

1,157,293

 

 

$

2,395,460

 

 

Net cash provided by operating activities for the year ended December 31, 2013 was $997,839. Cash was provided by the net operating income for year of $1,070,995, as well as the non-cash charges for depreciation of $571,682, amortization of $52,921, stock option expense of $8,946, warrant expense of $10,553, and loss on fixed assets written off of $19,221. Cash was decreased by $736,479 due to the following changes in our operating assets and liabilities:

 

Accounts receivable increase

 

$

(270,499

)

Inventories increase

 

 

(211,684

)

Prepaid expenses increase

 

 

(206,301

)

Amortizable intangible assets increase

 

 

(127,293

)

Deferred tax benefit decrease

 

 

93,838

 

Accounts payable decrease

 

 

(440,827

)

Accrued expenses increase

 

 

376,947

 

Deferred tax liability increase

 

 

49,340

 

Net change

 

$

(736,479

)

 

14

 

 

Accounts receivable increased by approximately $270,000 due to the increase in sales of approximately $1,400,000 from 2012 to 2013. Inventories increased by approximately $212,000 due to the increase in sales and increased demand for product. Prepaid expenses increased by approximately $210,000 due mostly to increased consulting and market research expenses. Accounts payable decreased by approximately $441,000 primarily due to the additional cash provided by higher sales and increased gross margin dollars. Accrued expenses increased by approximately $377,000 primarily due to increases in accrued profit sharing/bonus, accrued taxes payable, accrued rent expenses, and accrued warranty expenses.

 

Net cash used in investing activities for the year ended December 31, 2013 was $485,578. The funds were used primarily for the acquisition of tooling/molds for our new “simply scoop” product and our new “on demand selective feeder” product. Funds were also used for IT equipment to assist with wireless scanning capabilities.

 

Net cash used in financing activities in 2013 was $475,555. Approximately $382,000 was used to pay down term loan principal and capital leases. Payments on the bank line of credit used approximately $426,000. The cash dividend paid on preferred stock used approximately $52,000. The borrowing as part of the Lake County Economic Development loan program provided approximately $125,000 in cash, the new capital lease provided approximately $21,000 and issuances of common stock provided another approximately $238,000 in cash.

 

Net cash provided by operating activities for the year ended December 31, 2012 was $554,864. Cash was provided by the net operating income for the year of $192,740, as well as the non-cash charges for depreciation of $602,576, amortization of $41,418, stock option expense of $18,745, warrant expense of $36,425, and loss on sale of fixed assets of $24,470.

  

Accounts receivable increased in 2012 as sales in the fourth quarter of the year were almost $6,000,000 compared to approximately $5,000,000 in 2011. Inventories decreased approximately $446,000 due to planned sales of close-out initiatives. Accounts payable decreased approximately $886,000 primarily due to the decrease in inventories and funding of $350,000 in additional subordinated debt. Accrued expenses increased approximately $199,000 primarily due to increases in accrued profit sharing/bonus, accrued salaries/wages expenses, and accrued commission expenses.

 

Net cash used in investing activities for the year ended December 31, 2012 was $358,717. The funds were used primarily for the acquisition of tooling/molds, equipment, and IT equipment for wireless scanning capabilities.

 

Net cash used in financing activities in 2012 was $539,856. Approximately $543,000 was used to pay down term loan principal and capital leases. Payments on the bank line of credit used approximately $827,000. The cash dividend paid on preferred stock used approximately $52,000. Borrowing of a new $500,000 term loan from our bank provided $500,000 in cash, and other borrowings of $350,000 from new subordinated debt and $32,000 in capital leases provided another approximately $382,000 in cash.

 

Results of Operations

 

Year Ended December 31, 2013 Compared to Year Ended December 31, 2012

 

In the following discussion all references to 2013 are for the year ended December 31, 2013 and all references to 2012 are for the year ended December 31, 2012.

  

Net revenue in 2013 increased by approximately $1,393,000, or 6.9%, to $21,554,106 from $20,160,751 in 2012. Both price and volume increases accounted for this growth. We relied much less on close-out sales in 2013 than in 2012 to obtain our sales targets. Excluding “close-out” sales, sales grew by 9.5% from 2012 to 2013. Sales to distributors, e-commerce customers, national chains, and regional chains comprised 95% of our revenue. All of these customer types experienced growth from 2012 to 2013. The largest revenue dollar growth came from sales to distributors, which increased by approximately $627,000 from 2012 to 2013, followed by sales to e-commerce customers, which grew by approximately $356,000 during the same time period.

 

We continue to focus on three main channels: “grocery, drug, mass”, “pet specialty” , and E-Commerce. We will be tailoring our brands in the coming year to deliver products that are specifically marketed to these separate but equally important channels with the Pet Zone brand for the “grocery, drug, mass retail” channel, the OurPets brand for the “pet specialty” channel, and both brands for E-Commerce. In 2013, sales increased in each of these channels although sales grew much more significantly in the “grocery, drug, mass retail” and E-Commerce channels than the “pet specialty” channel. Sales in the “grocery, drug, mass retail” channel increased by approximately $2,447,000 as compared to an increase of only approximately $89,000 in the pet specialty channel from 2012 to 2013.

 

With respect to product by category sales, the $1,393,000 net revenue increase came from increased sales in bowl/feeders, catnip and tuna consumables and toys/accessories, which were offset by decreases in sales of feline waste and odor products.

 

15

 

 

Sales to all customers for new products in 2013 that were not sold in 2012 were approximately $1,986,000 or about 9.2% of our net revenue. Our hybrid stainless steel bonded rubber bowls that were introduced in the first quarter of 2013 accounted for approximately $1,207,000 of this total. 

 

Consolidated sales to foreign customers were $2,765,101, an increase of approximately $227,000, or 8.9%, from foreign sales of $2,538,174 in 2012. This increase was mainly due to increased sales to customers in Canada and the United Kingdom, which were offset by a decrease in sales to customers in Japan and Switzerland.

 

While net revenue increased by 6.9% in 2013, cost of goods sold only increased by a net of $172,034, or 1.2%, from $14,703,465 in 2012 to $14,875,499 in 2013. Cost of goods sold increased at a much smaller rate than sales due to more focus on selling higher margin products. During the year we also rolled out modest price increases. We also achieved some cost reductions as a result of working with our suppliers to find lower costs of production. The net change in cost of goods sold was the result of: approximately $76,000 in increased cost of purchased goods (caused by the increase in sales), approximately $33,000 in increased charges for excess and obsolete inventory, approximately $112,000 in increased operating expenses mostly related to increased warranty expenses, and a net decrease of approximately $49,000 in other expenses, including depreciation and payroll related expenses.

 

Gross profit margin increased by a net of 3.9% to 31.0% in 2013 from 27.1% in 2012 while gross profit dollars increased by a net of $1,221,321. The increase of our net sales by $1,393,355 contributed approximately $541,000 more to gross margin dollars than in 2012. Also in 2013, we decreased our variable operating costs by approximately $.025 cents for every dollar of sales by focusing less on close out sales and more on sales of our core, active products. By better controlling our variable costs, we added approximately $543,000 to the margin dollars for 2013. Likewise, we decreased our fixed operating costs by approximately $137,000 which added directly to the margin increase. Most of the decrease in fixed costs came from payroll and depreciation related expenses.

 

Our variable and fixed warehouse and overhead costs increased in total by approximately $56,000, or 2.2%, from the comparable twelve months in 2012 due to the increase in sales.

 

S, G & A expenses in 2013 were $4,960,802, a decrease of 1.7%, or $83,969, from $5,044,771 in 2012. This decrease was the net result of (i) an increase in salaries and wages, payroll taxes, and employee benefits of approximately $43,000, (ii) a decrease in sales and marketing expenses of approximately $246,000 mainly due to decreased warranty costs and corporate show expenses offset by increased advertising expenses, (iii) an increase in business and product development expenses of approximately $51,000, and (iv) an increase in professional expenses of approximately $46,000 most of which was attributable to increased consulting expenses. The remaining approximately $22,000 variance is comprised of numerous other S, G & A line items.  

 

 Our “income from operations” increased by approximately $1,305,000, from $412,515 in 2012 to $1,717,805 in 2013. This increase was the result of our gross profit on sales increasing by $1,221,321 while S, G & A expenses decreased by $83,969.

  

Other income for 2013 was $174,655, compared to other expense of $3,208 in 2012. The income in 2013 was primarily from patent litigation and insurance claim settlements. The expense in 2012 was primarily the net result of income from legal settlements, income from a grant received, and loss for fixed assets that were written off.

 

Interest expense for 2013 was $160,572, a slight increase of $2,303, or 1.5%, from $158,269 in 2012. This change was due to a combination of factors. Interest expense for our bank line of credit decreased by approximately $38,100, resulting from the reduction in our average balance to $1,766,833 in 2013 from $2,766,447 in 2012 (interest rate remained the same at 3.75%). More interest expense was incurred for term loans of approximately $6,100 due to the addition of a new $500,000 term loan in December of 2012. Interest expense due on notes payable to subordinated note holders increased by approximately $30,400 from 2012 as a result of additional borrowings at the end of 2012. Lastly, interest expense due on leases and other miscellaneous payments increased by approximately $3,900.

 

 Income tax expense in 2013 increased to $660,893 from $58,298 in 2012. The $602,595 increase was due to (i) an increase in the estimate for federal income tax expense due of approximately $482,000, (ii) an increase in the estimate of local income tax expense due of approximately $36,000, and (iii) a change in the deferred tax accounts of approximately $85,000.

 

The Company’s deferred tax assets of $93,838 were completely utilized in 2013. This was the result of the Company using its remaining tax loss carry forwards which were approximately $373,000 at December 31, 2012. Increases of Section 179 property deductions resulted in the Company recognizing an increase in deferred tax liabilities of approximately $49,000 as of December 31, 2013.

 

16

 

 

Net income increased by $878,255, from $192,740 in 2012 to $1,070,995 in 2013. This increase was as a result of the following changes from 2012 to 2013:

  

Net revenue increase of 6.9%

 

$

1,393,355

 

Cost of goods sold increase of 1.2%

 

 

(172,034

)

Gross profit increase of 22.4%

 

 

1,221,321

 

Selling, general and administrative expenses decrease of 1.7 %

 

 

83,969

 

Interest expense increase of 1.5%

 

 

(2,303

)

Other expense/income increase

 

 

177,863

 

Income tax expense increase

 

 

(602,595

)

Increase in profitability

 

$

878,255

 

 

Critical Accounting Policies/Estimates

 

We prepare our consolidated financial statements in accordance with United States generally accepted accounting principles. We have identified the accounting policies below as critical to our business operations and understanding of our results of operations. For a detailed discussion on the application of these and other accounting policies, see Summary of Significant Accounting Policies footnote to our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K. The application of these policies may require management to make judgments and estimates that affect the reported amount of assets and liabilities, disclosure of contingent assets and liabilities at the date of our financial statements, and the reported amounts of revenue and expenses during the reporting period. Management uses historical experience and all available information to make these estimates and judgments, and different amounts could be reported using different assumptions and estimates.

 

Inventories and inventory reserves. Inventories are stated at the lower of cost or net realizable value. We estimate net realizable value based on intended use, current market value and inventory aging analyses. We write down our inventory for estimated obsolescence or unmarketable inventory equal to the difference between the cost of inventory and the estimated market value based upon assumptions about future demand and market conditions. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required.

 

Impairment of Long-Lived Assets. We review long-lived assets for possible impairment by evaluating whether the carrying amount of assets exceed its recoverable amount. Our judgment regarding the existence of impairment is based on legal factors, market conditions and operational performance of our assets. Future adverse changes in legal environment, market conditions or poor operating results could result in losses or an inability to recover the carrying value of the long-lived assets, thereby possibly requiring an impairment charge in the future.

 

Intangible Assets. The Company adopted the provisions of ASC Topic 350 “Goodwill and Other Intangible Assets” which states that intangible assets that are subject to amortization are reviewed for potential impairment whenever events or circumstances indicate that carrying amounts may not be recoverable. Assets not subject to amortization are tested for impairment at least annually.

 

Income Taxes. Deferred income tax assets and liabilities are recorded for differences between the financial statement and tax bases of assets and liabilities that will result in taxable or deductible amounts in the future based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized.

 

Research and Development Expenses. Research and development expenditures are charged to operations when incurred and are included in cost of goods sold. If funding is not available from operations our ability to develop new and/or improved products could be adversely affected.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements that have or are likely to have a current or future effect on our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

17

 

 

Item 8. Financial Statements and Supplementary Data.

 

The financial statements of OurPet’s Company as of December 31, 2013 and 2012, and for the years then ended together with the Report of Independent Registered Public Accounting Firm are included in this Form 10-K on the pages indicated below.

 

 

 

Page No.

Report of Independent Registered Public Accounting Firm

 

28

Consolidated Balance Sheets

 

29-30

Consolidated Statements of Operations

 

31

Consolidated Statements of Stockholders’ Equity

 

32

Consolidated Statements of Cash Flows

 

33

Notes to Consolidated Financial Statements

 

34-47

 

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.

 

None

 

Item 9A. Controls and Procedures.

 

Evaluation of Controls and Procedures

 

As of December 31, 2013, we carried out an evaluation, under the supervision and with the participation of our management, including our President and Chief Executive Officer along with our Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934 (the Exchange Act”). Based upon that evaluation, our President and Chief Executive Officer and our Chief Financial Officer each concluded that our disclosure controls and procedures were effective as of December 31, 2013.

 

Management’s Report on Internal Control Over Financial Reporting

 

OurPet’s management is responsible for establishing and maintaining an adequate system of internal control over financial reporting as such term is defined in Rule 13a-15(f) of the Exchange Act. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of our consolidated financial statements for external purposes in accordance with U.S. generally accepted accounting principles defined in the Exchange Act.

 

The company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with accounting principles generally accepted in the United States of America, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements and even when determined to be effective, can only provide reasonable assurance with respect to financial statement preparation and presentation. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

We carried out an evaluation under the supervision and with the participation of our management, including our chief executive officer and chief financial officer, of the effectiveness of our internal control over financial reporting. In making this evaluation, management used the criteria set forth in Internal Control Integrated Framework (1992) issued by the Committee of Sponsoring Organizations (COSO) of the Treadway Commission. Based on this evaluation, management has concluded that the internal control over financial reporting was effective as of December 31, 2013.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting during our last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

18

 

 

Attestation Report of Independent Registered Public Accounting Firm

 

This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to the Securities and Exchange Commission rules that permit the Company to provide only management’s report in this annual report.

 

Item  9B. Other Information.

 

None.

 

PART III

 

Item 10. Directors, Executive Officers and Corporate Governance.

 

The information required by this Item is incorporated by reference from the information provided under the headings “Board of Directors,” and “Executive Officers,” contained in our Proxy Statement for our 2014 Annual Meeting of Shareholders to be held on May 21, 2014.

 

Item 11. Executive Compensation.

 

The information required by this Item is incorporated by reference from the information provided under the headings “Executive Compensation and Other Information” and “Board of Directors—Director Compensation” contained in our Proxy Statement for the 2014 Annual Meeting.

 

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.

 

Information required by this Item is incorporated herein by reference from the information provided under the headings “Executive Compensation and Other Information—Equity Compensation Plan Information” and “Principal Shareholders” of our Proxy Statement for the 2014 Annual Meeting.

 

Item 13. Certain Relationships and Related Transactions, and Director Independence.

 

The information required by this Item is incorporated herein by reference from the information provided under the heading “Certain Relationships and Related Transactions, and Board of Directors—Director Independence” of our Proxy Statement for the 2014 Annual Meeting.

 

Item 14. Principal Accountant Fees and Services.

 

The information required by this Item is incorporated by reference from the information provided under the heading “Principal Accountant Firm Fees” contained in our Proxy Statement for the 2014 Annual Meeting.

 

PART IV

 

Item 15. Exhibits and Financial Statement Schedules.

 

(a) Financial Statement Schedules

 

The following consolidated financial statements of the Company and its subsidiaries are incorporated by reference from Item 8 in Part II of this Form 10-K (see pages 28-47).

 

Report of Independent Registered Public Accounting Firm

28

Consolidated Balance Sheets

29-30

Consolidated Statements of Operations

31

Consolidated Statements of Stockholders’ Equity

32

Consolidated Statements of Cash Flows

33

Notes to Consolidated Financial Statements

34-47

 

19

 

 

All other schedules for which provision is made in the applicable accounting regulation of the SEC are omitted because of the absence of conditions under which they are required or because the required information is included in the consolidated financial statements and related notes thereto.

 

(b) Exhibits

 

2.1

Asset Purchase Agreement dated January 3, 2006, between the Company and Pet Zone Products Ltd.(5)

 

 

3.1

Articles of Incorporation of the Company, dated May 23, 1996.(1)

 

 

3.1.1

Articles of Amendment to the Articles of Incorporation of the Company, effective September 1, 1998.(1)

 

 

3.1.2

Articles of Amendment to the Articles of Incorporation of the Company, adopted July 20, 1999.(1)

 

 

3.1.3

Articles of Amendment to the Articles of Incorporation of the Company effective January 21, 2010.(16)

 

 

3.2

Bylaws of the Company.(1)

 

 

4.1

Common Stock Certificate.(1)

 

 

4.2

Preferred Stock Certificate.(1)

 

 

4.3

Promissory Note dated September 1, 1999 for $200,000, made by the Company to Joseph T. Aveni.(1)

 

 

4.4

Registration Rights Agreement dated January 3, 2006 among the Company, Pet Zone Products Ltd. and certain other stockholders.(5)

 

 

4.5

Voting Agreement dated January 3, 2006 among the Company, Steven Tsengas, Evangelia S. Tsengas, Konstantine S. Tsengas, Nicholas S. Tsengas, Senk Properties, Joseph T. Aveni, Carl Fazio, Jr., John G. Murchie, Pet Zone Products Ltd., Capital One Partners, LLC, LJR Limited Partnership, Nottingham Ventures, Ltd. and Spirk Ventures, Ltd.(5)

 

 

10.1

Asset Purchase Agreement, dated March 31, 2000, between Akon Plastic Enterprises, Inc. and Sanar Manufacturing Company, a wholly-owned subsidiary of OurPet’s Company.(1)

 

 

10.2

Lease Agreement dated March 17, 1993, with Addendums, between Senk Properties and GPI Division, Napro, Inc.(1)

 

 

10.5

1999 Stock Option Plan.(1)

 

 

10.6

Standard Option Agreement.(1)

 

 

10.7

Standard Common Stock Purchase Warrant.(1)

 

 

10.8

Indemnity Agreement, dated March 31, 2000, between Akon Plastic Enterprises, Inc. and its President, David Herman, individually, and OurPet’s Company and Dr. Steven Tsengas, Evangelia Tsengas, Nicholas Tsengas and Konstantine Tsengas.(1)

 

 

10.10

Small Business Administration loan agreement dated March 10, 1995 with Napro, Inc.(1)

 

 

10.12

Vendor Agreement between the Company and Wal-Mart Stores, Inc.(1)

 

 

10.17

PetsMart 2001 Vendor Purchasing Terms.(1)

 

 

10.18

Credit Agreement, Revolving Note and Security Agreements, dated December 31, 2001, between FirstMerit Bank, N.A., the Company, Virtu Company, Dr. Steven Tsengas and Evangelia S. Tsengas.(2)

 

 

10.19

Promissory Note dated February 1, 2004 for $75,000, made by the Company to Beachcraft Limited Partnership.(4)

 

 

10.20

Warrant issued to Pet Zone Products Ltd. to purchase 2,729,000 shares of the Company’s Common Stock dated January 4, 2006.(5)

 

20

 

 

10.21

Warrant issued to Pet Zone Products Ltd. to purchase 125,000 shares of the Company’s Common Stock dated January 4, 2006.(5)

 

 

10.22

Subordinated Promissory Note dated January 4, 2006 from the Company to Pet Zone Products Ltd.(5)

 

 

10.23

Commercial Security Agreement by and between the Company and FirstMerit Bank, N.A.(6)

 

 

10.24

Promissory Note executed by the Company in favor of FirstMerit Bank, N.A.(6)

 

 

10.25

Lease Agreement dated March 1, 2007 between Senk Properties and OurPet’s Company.(7)

 

 

10.26

Amended Subordinated Promissory Note dated as of October 18, 2006, executed by OurPet’s Company in favor of Pet Zone Products Ltd.(8)

 

 

10.27

Cat Litter Device Development Agreement dated January 15, 2007 by and between Nottingham-Spirk Design Associates, Inc. and OurPet’s Company.(9)

 

 

10.28

Form of Indemnification Agreement, by and between OurPet’s Company and each of its Directors.(9)

 

 

10.29

Amendment to Loan Agreement dated March 23, 2007 between FirstMerit Bank, N.A. and OurPet’s Company.(10)

 

 

10.30

Promissory Note dated March 23, 2007 executed by the Company in favor of FirstMerit Bank, N.A.(10)

 

 

10.31  

Commercial Security Agreement dated March 23, 2007 by and between the Company and FirstMerit Bank, N.A.(10)

 

 

10.32  

Contribution Agreement dated February 7, 2008 among OurPet’s Company, Capital One Partners LLC, Nottingham Ventures Ltd., Spirk Ventures Ltd. and LJR Limited Partnership.(11)

 

 

10.33

Contribution Agreement dated February 7, 2008 among OurPet’s Company, SENK Properties, LLC and Dr. William M. Fraser.(11)

 

 

10.34

Form of Promissory Note issued by OurPet’s to each Contributor.(11)

 

 

10.35

Form of Warrant issued by OurPet’s to each Contributor.(11)

 

 

10.36

Form of Registration Rights Agreement among OurPet’s and the Contributors.(11)

 

 

10.37

Contribution Agreement dated June 20, 2008 among OurPet’s Company, Capital One Partners LLC, Nottingham Ventures Ltd., Spirk Ventures Ltd. and LJR Limited Partnership.(12)

 

 

10.38

Contribution Agreement dated June 20, 2008 among OurPet’s Company, Senk Properties and Dr. William M. Fraser.(12)

 

 

10.39

Form of Promissory Note issued by OurPet’s to each Contributor.(12)

 

 

10.40

Form of Warrant issued by OurPet’s to each Contributor.(12)

 

 

10.41

Form of Registration Rights Agreement among OurPet’s and the Contributors.(12)

 

10.42

Fee Agreement dated November 25, 2008 between OurPet’s and Nottingham-Spirk Design Associates, Inc.(13)

 

 

10.43

2008 Stock Option Plan(14)

 

 

10.44

First Amendment to the 2008 Stock Option Plan(15)

 

 

10.45

Business Loan Agreement (Asset Based), dated September 17, 2009, between OurPet’s Company and FirstMerit Bank, N.A.(17)

 

 

10.46

Amendment to Note, dated September 17, 2009, between OurPet’s Company and FirstMerit Bank, N.A.(17)

 

 

10.47

Promissory Note, dated September 17, 2009, executed by OurPet’s Company in favor of FirstMerit Bank, N.A.(17)

 

21

 

 

10.48

Form of Warrant.(17)

 

 

10.49

Asset Purchase Agreement among Cosmic Pet Products, Inc., Confusion, Inc., Leon Seidman and OurPet’s Company dated June 28, 2010.(18)

 

 

10.50

Commercial Security Agreement, dated July 16, 2010, between OurPet’s Company and FirstMerit Bank, N.A.(19)

 

 

10.51

Promissory Note, dated July 16, 2010, executed by OurPet’s Company in favor of FirstMerit Bank, N.A.(19)

 

 

10.52

Amendment to Note executed by OurPet’s Company, and Steven and Evangelia Tsengas as Guarantors, on October 18, 2010.(20)

 

 

10.53

Form of Warrant.(20)

 

 

10.54

Promissory Note, dated November 30, 2010, executed by OurPet’s Company in favor of FirstMerit Bank, N.A.(21)

 

 

10.55

Commercial Security Agreement, dated November 30, 2010, between OurPet’s Company and FirstMerit Bank, N.A.(21)

 

 

10.56

Promissory Note, dated January 19, 2011, executed by OurPet’s Company in favor of FirstMerit Bank, N.A.(22)

 

 

10.57

Commercial Security Agreement, dated January 19, 2011, between OurPet’s Company and FirstMerit Bank, N.A.(22)

 

 

10.58

Amended and Restated Promissory Note dated June 28, 2011, executed by OurPet’s Company.(23)

 

 

10.59

Business Loan Agreement (Asset Based) dated June 28 2011, executed by OurPet’s Company and FirstMerit Bank, N.A. (23)

 

 

10.60

Loan Agreement dated May 19, 2011, executed by OurPet’s and the Director of Development of the State of Ohio.(24)

 

 

10.61

Cognovit Promissory Note dated May 19, 2011, executed by OurPet’s in favor of the Director of Development of the State of Ohio.(24)

 

 

10.62

Security Agreement dated May 19, 2011, executed by OurPet’s and the Director of Development of the State of Ohio.(24)

 

 

10.63

Form of Warrant issued to Steven and Evangelia Tsengas.(24)

 

 

10.64

Lease Agreement dated December 30, 2011, between OurPet’s Company and Senk Properties LLC.(25)

 

 

10.65

Separation Severance Agreement dated February 13, 2012, between OurPet’s Company and John M. Silvestri.(26)

 

 

10.66

Amendment to Loan Agreement dated March 26, 2012, between OurPets Company and FirstMerit Bank, N.A.(27)

 

 

10.67

Lease Agreement dated August 10, 2012, between OurPet’s Company and Senk Properties LLC.(28)

 

 

10.68

Form of Promissory Note issued by OurPet’s Company on November 8, 2012.(29)

 

 

10.69

Form of Warrant issued by OurPet’s Company on November 8, 2012.(29)

 

 

10.70

Covenant Waiver issued by FirstMerit Bank to OurPet’s Company on November 5, 2012.(29)

 

 

10.71

Business Loan Agreement (Asset Based), dated December 7, 2012, between OurPet’s Company and FirstMerit Bank, N.A.(30)

 

 

10.72

Amendment to Note, dated December 7, 2012, between OurPet’s Company, SMP Company, Incorporated, Virtu Company and FirstMerit Bank, N.A.(30)

 

 

10.73

Promissory Note, dated December 7, 2012, executed by OurPet’s Company, SMP Company, Incorporated and Virtu Company in favor of FirstMerit Bank, N.A.(30)

 

 

10.74

Commercial Security Agreement, dated December 7, 2012, by and among OurPet’s Company, as Grantor, and FirstMerit Bank, N.A., as Lender.(30)

 

22

 

 

10.75

Commercial Security Agreement, dated December 7, 2012, by and among SMP Company, Incorporated, as Grantor, and FirstMerit Bank, N.A., as Lender.(30)

 

 

10.76

Commercial Security Agreement, dated December 7, 2012, by and among Virtu Company, as Grantor, and FirstMerit Bank, N.A., as Lender.(30)

 

 

10.77

Form of Warrant issued by OurPet’s Company on December 7, 2012.(30)

 

 

10.78

Employment Agreement dated May 31, 2013 between Scott R. Mendes and OurPet’s Company. (31)

 

 

10.79

Employment Agreement dated May 31, 2013, 2013 between Konstantine S. Tsengas and OurPet’s Company. (31)

 

 

10.80

Loan Agreement, dated June 20, 2013, between OurPet’s Company and the Board of Lake County Commissioners. (32)

 

 

10.81

Cognovit Promissory Note, dated June 20, 2013, executed by OurPet’s Company in favor of the Board of Lake County Commissioners. (32)

 

 

10.82

Security Agreement, dated December June 20, 2013, between OurPet’s Company and the Board of Lake County Commissioners. (32)

 

 

10.83

Amendment to Note, dated November 12, 2013, between OurPet’s Company, SMP Company, Incorporated, Virtu Company and FirstMerit Bank, N.A. (33)

 

 

11

Statement of computation of Net Income Per Share.

 

 

14

OurPet’s Code of Ethics.(3)

 

 

21

Subsidiaries of the Registrant.(1)

 

 

31.1

Certification of the Chief Executive Officer pursuant to 17 CFR Section 240.13a-14(a) of the Sarbanes-Oxley Act of 2002.

 

 

31.2

Certification of the Principal Financial Officer pursuant to 17 CFR Section 240.13a-14(a) of the Sarbanes-Oxley Act of 2002.

 

 

32.1

Certification of the President and Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

32.2

Certification of the Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 

 

101

In Accordance with the Temporary Hardship Exemption provided by Rule 201 of Regulation S-T, the date by which the interactive data file is required to be submitted has been extended by six business days. 

 

(1)

Incorporated by reference to the exhibits to the Company’s Registration Statement on Form 10SB/A filed on May 31, 2001.

 

(2)

Incorporated by reference to the exhibits to the Company’s Annual Report on Form 10-KSB filed on March 26, 2002.

 

(3)

Incorporated by reference to the exhibits to the Company’s Annual Report on Form 10-KSB filed on March 26, 2004.

 

(4)

Incorporated by reference to the exhibits to the Company’s Annual Report on Form 10-KSB filed on March 30, 2005.

 

(5)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on January 6, 2006.

 

(6)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on August 18, 2006.

 

(7)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on August 25, 2006.

 

(8)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on October 23, 2006.

 

23

 

 

(9)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on January 19, 2006.

 

(10)

Incorporated by reference to the exhibits to the Company’s Annual Report of Form 10-KSB filed on March 28, 2007.

 

(11)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on February 12, 2008.

 

(12)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on June 25, 2008.

 

(13)

Incorporated by reference to the Exhibits to the Company’s Form 8-K filed on December 2, 2008.

 

(14)

Incorporated by reference to Annex A to the Company’s Proxy Statement filed on May 7, 2008.

 

(15)

Incorporated by reference to the exhibits to the Company’s Annual Report on Form 10-K filed on March 31, 2009.

 

(16)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on January 27, 2010.

 

(17)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on September 23, 2009.

 

(18)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on July 1, 2010.

 

(19)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on July 22, 2010.

 

(20)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on October 22, 2010.

 

(21)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on December 2, 2010.

 

(22)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on January 24, 2011.

 

(23)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on July 5, 2011.

 

(24)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on October 6, 2011.

 

(25)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on January 5, 2012.

 

(26)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on February 17, 2012.

 

(27)

Incorporated by reference to the exhibits to the Company’s Annual Report on Form 10-K filed on March 30, 2012.

 

(28)

Incorporated by reference to the exhibits to the Company’s Quarterly Report on Form 10-Q filed on August 14, 2012.

 

(29)

Incorporated by reference to the exhibits to the Company’s Quarterly Report on Form 10-Q filed on November 14, 2012.

 

(30)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on December 13, 2012.

 

(31)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on June 3, 2013.

 

(32)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on June 25, 2013.

 

(33)

Incorporated by reference to the exhibits to the Company’s Form 8-K filed on November 18, 2013.

 

All other Exhibits filed herewith. 

 

24

 

 

SIGNATURES

 

In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Dated: March 31, 2014

  

 

OURPET’S COMPANY

 

 

 

 

By:

/S/    STEVEN TSENGAS

 

 

Steven Tsengas

 

 

Chairman and Chief

Executive Officer

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

 

 

 

 

 

/S/    STEVEN TSENGAS

 

Chairman, Chief Executive Officer and

 

March 31, 2014

Steven Tsengas

 

Director (Principal Executive Officer)

 

 

 

 

 

 

 

/S/    SCOTT R. MENDES

 

Chief Financial Officer

 

March 31, 2014

Scott R. Mendes

 

(Principal Accounting Officer)

 

 

 

 

 

 

 

/S/    JOSEPH T. AVENI

 

Director

 

March 31, 2014

Joseph T. Aveni

 

 

 

 

 

 

 

 

 

/S/    WILLIAM L. LECHTNER

 

Director

 

March 31, 2014

William L. Lechtner

 

 

 

 

 

 

 

 

 

/S/    CHARLES C. MACMILLAN

 

Director

 

March 31, 2014

Charles C. MacMillan

 

 

 

 

 

 

 

 

 

/S/    JOHN W. SPIRK, JR.

 

Director

 

March 31, 2014

John W. Spirk,  Jr.

 

 

 

 

 

25

 

 

OURPET’S COMPANY AND SUBSIDIARIES

 

FAIRPORT HARBOR, OHIO

 

FINANCIAL STATEMENTS

 

DECEMBER 31, 2013

 

and

 

DECEMBER 31, 2012

 

 

 

 

OURPET’S COMPANY AND SUBSIDIARIES

FINANCIAL STATEMENTS

 

 

Page

 

Number

 

 

Report of Independent Registered Public Accounting Firm

28

 

 

Consolidated Balance Sheets as of December 31, 2013 and December 31, 2012

29 – 30

 

 

Consolidated Statements of Operations for the years ended December 31, 2013 and December 31, 2012

31

 

 

Consolidated Statements of Stockholders’ Equity for the years ended December 31, 2013 and December 31, 2012

32

 

 

Consolidated Statements of Cash Flows for the years ended December 31, 2013 and  December 31, 2012

33

 

 

Notes to Consolidated Financial Statements

34 - 47

 

27

 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Stockholders and Board of Directors

OurPet’s Company and Subsidiaries

 

We have audited the accompanying consolidated balance sheets of OurPet’s Company and Subsidiaries (the “Company”), a Colorado corporation, as of December 31, 2013 and 2012, and the related consolidated statements of operations, stockholders’ equity, and cash flows for the years then ended. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

 

We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

 

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the consolidated financial position of OurPet’s Company and Subsidiaries as of December 31, 2013 and 2012, and the consolidated results of their operations and its cash flows for each of the years in the two year period ended December 31, 2013 in conformity with accounting principles generally accepted in the United States of America.

 

 

/s/ NMS, Inc.

Certified Public Accountants

 

Mentor, Ohio

March 28, 2014

 

28

 

  

OURPET'S COMPANY AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS 

 

 

 

December 31,

 

 

 

2013

 

 

2012

 

 

 

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 CURRENT ASSETS

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

57,975

 

 

$

21,269

 

Accounts receivable - trade, less allowance for doubtful accounts of $28,014 and $37,873

 

 

2,811,139

 

 

 

2,540,640

 

Inventories net of reserve

 

 

5,876,724

 

 

 

5,665,040

 

Prepaid expenses

 

 

397,268

 

 

 

190,967

 

Deferred Tax Asset

 

 

-

 

 

 

93,838

 

Total current assets

 

 

9,143,106

 

 

 

8,511,754

 

 

 

 

 

 

 

 

 

 

 PROPERTY AND EQUIPMENT

 

 

 

 

 

 

 

 

Computers and office equipment

 

 

717,383

 

 

 

664,745

 

Warehouse equipment

 

 

553,148

 

 

 

518,304

 

Leasehold improvements

 

 

263,731

 

 

 

244,832

 

Tooling

 

 

4,059,740

 

 

 

3,869,758

 

Construction in progress

 

 

349,164

 

 

 

337,239

 

Total

 

 

5,943,166

 

 

 

5,634,878

 

Less accumulated depreciation

 

 

4,051,957

 

 

 

3,638,343

 

Net property and equipment

 

 

1,891,209

 

 

 

1,996,535

 

 

 

 

 

 

 

 

 

 

 OTHER ASSETS

 

 

 

 

 

 

 

 

Amortizable Intangible Assets, less amortization of $337,996 and $285,075

 

 

370,850

 

 

 

296,478

 

Intangible Assets

 

 

461,000

 

 

 

461,000

 

Goodwill

 

 

67,511

 

 

 

67,511

 

Deposits and other assets

 

 

18,003

 

 

 

18,003

 

Total other assets

 

 

917,364

 

 

 

842,992

 

 

 

 

 

 

 

 

 

 

Total assets

 

$

11,951,679

 

 

$

11,351,281

 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

29

 

 

OURPET'S COMPANY AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS (CONTINUED) 

 

 

 

December 31,

 

 

 

2013

 

 

2012

 

 

 

 

 

 

 

 

LIABILITIES

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 CURRENT LIABILITIES

 

 

 

 

 

 

 

 

Notes payable

 

$

100,000

 

 

$

100,000

 

Current maturities of long-term debt

 

 

397,575

 

 

 

517,531

 

Accounts payable - trade

 

 

1,169,925

 

 

 

1,610,752

 

Income taxes payable

 

 

161,637

 

 

 

-

 

Other accrued expenses

 

 

699,373

 

 

 

484,063

 

Total current liabilities

 

 

2,528,510

 

 

 

2,712,346

 

 

 

 

 

 

 

 

 

 

 LONG-TERM LIABILITIES

 

 

 

 

 

 

 

 

Long-term debt - less current portion above

 

 

721,389

 

 

 

837,150

 

Revolving Line of Credit

 

 

1,833,032

 

 

 

2,259,032

 

Deferred Income Taxes

 

 

245,775

 

 

 

196,435

 

Total long term liabilities

 

 

2,800,196

 

 

 

3,292,617

 

 

 

 

 

 

 

 

 

 

Total liabilities

 

 

5,328,706

 

 

 

6,004,963

 

 

 

 

 

 

 

 

 

 

 STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

 COMMON STOCK

 

 

 

 

 

 

 

 

No par value; 50,000,000 shares authorized, 16,657,660 and 15,883,560 shares issued and outstanding at December 31, 2013 and December 31, 2012 respectively

 

 

4,901,563

 

 

 

4,583,232

 

 

 

 

 

 

 

 

 

 

CONVERTIBLE PREFERRED STOCK

 

 

 

 

 

 

 

 

No par value; convertible into Common Stock at the rate of 10 common shares for each preferred share; 5,000,000 shares authorized, 63,500 and 66,000 shares issued and outstanding at December 31, 2013 December 31, 2012 respectively

 

 

579,850

 

 

 

602,679

 

 

 

 

 

 

 

 

 

 

Series 2009 no par value; convertible into Common Stock at the rate of 10 common shares for each preferred share; 175,000 shares authorized, 123,616 shares issued and outstanding at December 31, 2013 and December 31, 2012

 

 

865,312

 

 

 

865,312

 

 

 

 

 

 

 

 

 

 

PAID-IN CAPITAL

 

 

19,498

 

 

 

-

 

 

 

 

 

 

 

 

 

 

ACCUMULATED EARNINGS (DEFICIT)

 

 

256,750

 

 

 

(704,905

)

Total stockholders' equity

 

 

6,622,973

 

 

 

5,346,318

 

 

 

 

 

 

 

 

 

 

Total liabilities and stockholders' equity

 

$

11,951,679

 

 

$

11,351,281

 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

30

 

 

CONSOLIDATED STATEMENTS OF OPERATIONS

 

 

 

For the Year Ended Dec. 31,

 

 

 

2013

 

 

2012

 

 

 

 

 

 

 

 

 Net revenue

 

$

21,554,106

 

 

$

20,160,751

 

 

 

 

 

 

 

 

 

 

 Cost of goods sold

 

 

14,875,499

 

 

 

14,703,465

 

 

 

 

 

 

 

 

 

 

 Gross profit on sales

 

 

6,678,607

 

 

 

5,457,286

 

 

 

 

 

 

 

 

 

 

 Selling, general and administrative expenses

 

 

4,960,802

 

 

 

5,044,771

 

 

 

 

 

 

 

 

 

 

 Income from operations

 

 

1,717,805

 

 

 

412,515

 

 

 

 

 

 

 

 

 

 

 Other (income) and expense

 

 

(174,655

)

 

 

3,208

 

 Interest expense

 

 

160,572

 

 

 

158,269

 

 

 

 

 

 

 

 

 

 

 Income before income taxes

 

 

1,731,888

 

 

 

251,038

 

 

 

 

 

 

 

 

 

 

 Income tax expense

 

 

(660,893

)

 

 

(58,298

)

 

 

 

 

 

 

 

 

 

 Net income

 

$

1,070,995

 

 

$

192,740

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Basic and Diluted Earnings Per Common Share

 

 

 

 

 

 

 

 

   After Dividend Requirements For Preferred

 

 

 

 

 

 

 

 

   Stock:

 

 

 

 

 

 

 

 

     Net Income

 

$

0.06

 

 

$

0.01

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Weighted average number of common shares

 

 

 

 

 

 

 

 

     outstanding used to calculate

 

 

 

 

 

 

 

 

     basic earnings per share

 

 

16,149,942

 

 

 

15,822,729

 

 

 

 

 

 

 

 

 

 

 Weighted average number of common and

 

 

 

 

 

 

 

 

    equivalent shares outstanding used to

 

 

 

 

 

 

 

 

    calculate diluted earnings per share

 

 

18,256,177

 

 

 

16,223,172

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

31

 

 

OURPET'S COMPANY AND SUBSIDIARIES

 

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

 

FOR THE YEARS ENDED DECEMBER 31, 2013 AND DECEMBER 31, 2012 

 

 

 

Preferred Stock

 

 

Series 2009 Preferred Stock

 

 

Common Stock

 

 

 

 

 

 

 

 

Total

 

 

 

Number of

 

 

 

 

 

Number of

 

 

 

 

 

Number of

 

 

 

 

 

Paid-In

 

 

Accumulated

 

 

Stockholders'

 

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Shares

 

 

Amount

 

 

Capital

 

 

Earnings (Deficit)

 

 

Equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2011

 

 

66,000

 

 

$

602,679

 

 

 

123,616

 

 

$

865,312

 

 

 

15,809,023

 

 

$

4,554,192

 

 

$

-

 

 

$

(871,855

)

 

$

5,150,328

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock issued upon exercise of stock options

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

8,537

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Common Stock issued in payment of Preferred Stock dividend

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

66,000

 

 

 

29,040

 

 

 

(29,040

)

 

 

-

 

 

 

-

 

Cash Dividend paid on Preferred Stock

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(26,130

)

 

 

(25,790

)

 

 

(51,920

)

Net income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

192,740

 

 

 

192,740

 

Stock-Based compensation expense

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

55,170

 

 

 

-

 

 

 

55,170

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2012

 

 

66,000

 

 

$

602,679

 

 

 

123,616

 

 

$

865,312

 

 

 

15,883,560

 

 

$

4,583,232

 

 

$

-

 

 

$

(704,905

)

 

$

5,346,318

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Common Stock issued upon exercise of stock options

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

307,911

 

 

 

148,500

 

 

 

 

 

 

 

-

 

 

 

148,500

 

Common Stock issued upon exercise of Warrants

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

375,189

 

 

 

89,582

 

 

 

 

 

 

 

 

 

 

 

89,582

 

Stock-Based compensation expense

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

19,498

 

 

 

 

 

 

 

19,498

 

Common Stock issued in payment of Preferred Stock dividend

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

66,000

 

 

 

57,420

 

 

 

 

 

 

 

(57,420

)

 

 

-

 

Conversion of Preferred shares to common stock

 

 

(2,500

)

 

$

(22,829

)

 

 

 

 

 

 

 

 

 

 

25,000

 

 

 

22,829

 

 

 

 

 

 

 

 

 

 

 

-

 

Cash Dividend paid on Preferred Stock

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

(51,920

)

 

 

(51,920

)

Net income

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,070,995

 

 

 

1,070,995

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at December 31, 2013

 

 

63,500

 

 

$

579,850

 

 

 

123,616

 

 

$

865,312

 

 

 

16,657,660

 

 

$

4,901,563

 

 

$

19,498

 

 

$

256,750

 

 

$

6,622,973

 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

32

 

 

OURPET'S COMPANY AND SUBSIDIARIES

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

 

 

For the Years Ended

 

 

 

December 31,

 

 

 

2013

 

 

2012

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

 

 

Net income

 

$

1,070,995

 

 

$

192,740

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

 

 

Loss on Fixed Assets Written Off

 

 

19,222

 

 

 

24,470

 

Depreciation expense

 

 

571,682

 

 

 

602,576

 

Amortization expense

 

 

52,921

 

 

 

41,418

 

Stock option expense

 

 

8,945

 

 

 

18,745

 

Warrant expense

 

 

10,553

 

 

 

36,425

 

(Increase) decrease in assets:

 

 

 

 

 

 

 

 

Accounts receivable - trade

 

 

(270,499

)

 

 

(170,618

)

Inventories

 

 

(211,684

)

 

 

446,278

 

Prepaid expenses

 

 

(206,301

)

 

 

51,360

 

Deferred Tax Asset less Valuation Allowance

 

 

93,838

 

 

 

61,441

 

Amortizable Intangible Asset Additions

 

 

(127,293

)

 

 

(58,273

)

Deposits and other assets

 

 

-

 

 

 

(1,577

)

Increase (decrease) in liabilities:

 

 

 

 

 

 

 

 

Accounts payable - trade

 

 

(440,827

)

 

 

(886,139

)

Accrued expenses

 

 

376,947

 

 

 

199,160

 

Deferred tax liabilities

 

 

49,340

 

 

 

(3,142

)

Net cash provided by operating activities

 

 

997,839

 

 

 

554,864

 

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

 

 

 

Acquisition of property and equipment

 

 

(485,578

)

 

 

(358,717

)

Net cash used in investing activities

 

 

(485,578

)

 

 

(358,717

)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

 

 

Principal payments on long-term debt

 

 

(381,533

)

 

 

(543,170

)

Principal borrowings of long-term debt

 

 

145,816

 

 

 

882,166

 

  Net payment on bank line of credit

 

 

(426,000

)

 

 

(826,932

)

Issuances of Common Stock

 

 

238,082

 

 

 

-

 

Dividends paid on Preferred Stock

 

 

(51,920

)

 

 

(51,920

)

Net cash used in financing activities

 

 

(475,555

)

 

 

(539,856

)

Net increase (decrease) in cash

 

 

36,706

 

 

 

(343,709

)

 

 

 

 

 

 

 

 

 

CASH AT BEGINNING OF PERIOD

 

 

21,269

 

 

 

364,978

 

CASH AT END OF PERIOD

 

$

57,975

 

 

$

21,269

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION

 

 

 

 

 

 

 

 

Interest paid

 

$

197,254

 

 

$

134,360

 

Income taxes paid

 

$

340,000

 

 

 

-

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURE OF NON CASH TRANSACTIONS

 

 

 

 

 

 

 

 

Non cash exercise of stock options/ warrants

 

$

110,585

 

 

$

3,500

 

Common Stock issued in payment of Preferred Stock Dividend

 

$

57,420

 

 

$

29,040

 

Equipment Obtained Through Capital Lease

 

$

20,816

 

 

$

34,880

 

Conversion of preferred shares into Common Stock

 

$

22,829

 

 

 

 

 

 

The accompanying notes are an integral part of the consolidated financial statements.

 

33

 

 

OURPET’S COMPANY AND SUBSIDIARIES

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

Summary of Significant Accounting Policies

 

Organization and Nature of Operations – OurPet’s Company (the “Company”) management originally founded Napro, Inc. (“Napro”), an Ohio corporation, in 1985 as an enterprise for launching new ventures and acquiring companies in various lines of business. In February 1996 Napro formed a wholly-owned Ohio subsidiary, Virtu Company (“Virtu”), to market proprietary products to the retail pet business under the OurPet’s label. Napro then changed its name to OurPet’s Company effective March 19, 1998.

 

The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles and include the accounts of the Company and its wholly owned subsidiaries. Intercompany transactions and balances have been eliminated in consolidation.

 

Use of Estimates - The preparation of the consolidated financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Policy of Cash Equivalents – For purposes of the financial statements, cash equivalents include time deposits, certificates of deposit and all highly liquid debt instruments with original maturities of three months or less when purchased.

 

Accounts Receivable – Accounts receivable have been adjusted for all known uncollectible accounts. An allowance for possible bad debts was established at December 31, 2013 and 2012 in the amount of $28,014 and $37,873, respectively. Management reviews accounts receivable on a regular basis, based on contracted terms and how recently payments have been received, to determine if any such amounts will potentially be uncollected. After all attempts to collect a receivable have failed, the receivable is written off. In 2013, the Company purchased a credit risk insurance policy that covers most of its International customers. As a result of that policy, the allowance for uncollectible accounts has been reduced despite the fact that accounts receivable increased.

 

Inventory - Inventories are carried at the lower of cost or estimated net realizable value. Costs for finished goods, components, packaging, and work in process are determined under the first-in, first-out method. Inventories at December 31, 2013 and December 31, 2012 consist of:

 

 

 

2013

 

 

2012

 

Finished goods

 

$

4,593,715

 

 

$

4,224,194

 

Components, packaging and work in process

 

 

1,417,998

 

 

 

1,544,431

 

Inventory reserve

 

 

(134,989

)

 

 

(103,585

)

Total

 

$

5,876,724